A Day Up For ORIC Pharmaceuticals, Inc.

Thu, Dec 22, 2022 at 07:03 PM
A Day Up For ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) shot up at $4.79, representing a gain of 59.7%. On Thu, Dec 22, 2022, ORIC:NASDAQ touched a New 2-Week High of $4.79. The stock appeared on our News Catalysts scanner on Thu, Dec 22, 2022 at 10:44 AM in the 'PATNERSHIP' category. From Thu, Dec 08, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days

About ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ)

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.